Cargando…
Targeting Engineered Nanoparticles for Breast Cancer Therapy
Breast cancer (BC) is the second most common cancer in women globally after lung cancer. Presently, the most important approach for BC treatment consists of surgery, followed by radiotherapy and chemotherapy. The latter therapeutic methods are often unsuccessful in the treatment of BC because of the...
Autores principales: | Ganesan, Kumar, Wang, Yan, Gao, Fei, Liu, Qingqing, Zhang, Chen, Li, Peng, Zhang, Jinming, Chen, Jianping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623926/ https://www.ncbi.nlm.nih.gov/pubmed/34834243 http://dx.doi.org/10.3390/pharmaceutics13111829 |
Ejemplares similares
-
A Review of the Pharmacological Potential of Spatholobus suberectus Dunn on Cancer
por: Zhang, Feng, et al.
Publicado: (2022) -
Unraveling the Role of Hepatic PGC1α in Breast Cancer Invasion: A New Target for Therapeutic Intervention?
por: Ganesan, Kumar, et al.
Publicado: (2023) -
iRGD-modified lipid–polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability
por: Gao, Fei, et al.
Publicado: (2017) -
The Role of Exosomal MicroRNAs in the Tumor Microenvironment of Breast Cancer
por: Liu, Qingqing, et al.
Publicado: (2019) -
The Antitriple Negative Breast cancer Efficacy of Spatholobus suberectus Dunn on ROS-Induced Noncanonical Inflammasome Pyroptotic Pathway
por: Zhang, Feng, et al.
Publicado: (2021)